tetano
Editor, Senior Moderator
Bone Marrow Transplant. 2011 Jan 17. [Epub ahead of print]
Infections with the 2009 H1N1 influenza virus among hematopoietic SCT recipients: a single center experience.
Rihani R, Hayajneh W, Sultan I, Ghatasheh L, Abdel-Rahman F, Hussein N, Hussein A, Al-Zaben A, Sarhan M, Saad M.
Bone Marrow and Stem Cell Transplantation program, King Hussein Cancer Center (KHCC), Amman, Jordan.
Abstract
We retrospectively reviewed medical records of 39 hematopoietic SCT (HSCT) recipients who presented at our hospital between 1 October 2009 and 31 January 2010 with the 2009 H1N1 influenza infection. The median age at presentation was 13.8 years (range: 3.3-56.9), infections developed at a median of 585 days (range: 0-2316) post transplant, the majority (n=27, 69%) occurred in allogeneic HSCT recipients, 12 (31%) patients were on immunosuppressive therapy and 12 (31%) had GVHD. Lower airway disease was present in 8 patients (21%). In total, 15 patients (39%) were hospitalized with a median duration of 4.5 days (range: 3-27 days) and 3 (8%) required mechanical ventilation; 2 of whom died.Bone Marrow Transplantation advance online publication, 17 January 2011; doi:10.1038/bmt.2010.329.
PMID: 21243021 [PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/21243021
Infections with the 2009 H1N1 influenza virus among hematopoietic SCT recipients: a single center experience.
Rihani R, Hayajneh W, Sultan I, Ghatasheh L, Abdel-Rahman F, Hussein N, Hussein A, Al-Zaben A, Sarhan M, Saad M.
Bone Marrow and Stem Cell Transplantation program, King Hussein Cancer Center (KHCC), Amman, Jordan.
Abstract
We retrospectively reviewed medical records of 39 hematopoietic SCT (HSCT) recipients who presented at our hospital between 1 October 2009 and 31 January 2010 with the 2009 H1N1 influenza infection. The median age at presentation was 13.8 years (range: 3.3-56.9), infections developed at a median of 585 days (range: 0-2316) post transplant, the majority (n=27, 69%) occurred in allogeneic HSCT recipients, 12 (31%) patients were on immunosuppressive therapy and 12 (31%) had GVHD. Lower airway disease was present in 8 patients (21%). In total, 15 patients (39%) were hospitalized with a median duration of 4.5 days (range: 3-27 days) and 3 (8%) required mechanical ventilation; 2 of whom died.Bone Marrow Transplantation advance online publication, 17 January 2011; doi:10.1038/bmt.2010.329.
PMID: 21243021 [PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/21243021